Please login to the form below

Not currently logged in
Email:
Password:

free-spending

This page shows the latest free-spending news and features for those working in and with pharma, biotech and healthcare.

A frugal future

A frugal future

more. But that environment is changing. Free-spending, arguably profligate life science companies will die out and frugal, ruthlessly efficient companies will replace them. ... Free-spending, arguably profligate life science companies will die out and

Latest news

  • Life sciences minister: Go digital for NHS savings Life sciences minister: Go digital for NHS savings

    Greater use of health technology could free funds for drug spending, says George Freeman.

  • GSK accused of intimidation

    GSK also lobbied on the Medicare prescription drug programme, legislation which proposes an expansion of child healthcare, government spending on health programmes and several free trade agreements, according to the form

  • News in brief, April 25, 2007

    The 33 countries also included three candidate countries: Croatia, Macedonia, Turkey and the European Free Trade Area (EFTA) nations Iceland, Norway and Switzerland. ... Pharmaceutical firms say that if the legislation went ahead, it would impact their

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics